Outcomes of Patients with Relapsed/Refractory Lymphoplasmacytic Lymphoma Treated with Venetoclax: A Multicenter Retrospective Analysis
Year: 2023
Type: conference-abstract
Source: Blood
Authors: Yazeed Sawalha, Shayna R Sarosiek, Rina Li Welkie, Sherif Seif, Shrinjaya Thapa, Saurabh Zanwar, Kirk Cahill, Rachel Treitman, Haikoo Shah, Shagun Arora, Georgios Pongas, Allison Winter, Ajay Major, Peter A. Riedell, Maria Lia Palomba, Prashant Kapoor, Ariel F. Grajales-Cruz, Kenneth H. Shain, Sheeba K. Thomas, Jorge J. Castillo
Institutions: The Ohio State University Wexner Medical Center, Dana-Farber Cancer Institute, The University of Texas MD Anderson Cancer Center, Moffitt Cancer Center, Mayo Clinic, University of Chicago, University of Colorado Denver, Cleveland Clinic, University of California, San Francisco, University of Miami, University of Colorado Cancer Center, Memorial Sloan Kettering Cancer Center
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4389234941